(Q44672192)

English

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial (English)

1 reference

Europe PubMed Central

5 December 2017

atrial fibrillation

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

S Bertil Olsson

1

1 reference

Europe PubMed Central

5 December 2017

Executive Steering Committee of the SPORTIF III Investigators

2

1 reference

Europe PubMed Central

5 December 2017

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

362

1 reference

Europe PubMed Central

5 December 2017

1691-1698

1 reference

Europe PubMed Central

5 December 2017

9397

1 reference

Europe PubMed Central

5 December 2017

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic therapy in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions of warfarin with drugs and food

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Why do patients with atrial fibrillation not receive warfarin?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of age on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

No Influence of Ethnic Origin on the Pharmacokinetics and Pharmacodynamics of Melagatran Following Oral Administration of Ximelagatran, a Novel Oral Direct Thrombin Inhibitor, to Healthy Male Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ximelagatran, an oral direct thrombin inhibitor, has a low potential for cytochrome P450-mediated drug-drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The Barthel ADL Index: a reliability study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Practical issues in equivalence trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke prevention in nonvalvular atrial fibrillation: A review of prospective randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914841-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(03)14841-6

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44672192&oldid=2031291959"